These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 3512116

  • 21. Use of human liver S9 in the Ames test: assay of three procarcinogens using human S9 derived from multiple donors.
    Hakura A, Suzuki S, Sawada S, Sugihara T, Hori Y, Uchida K, Kerns WD, Sagami F, Motooka S, Satoh T.
    Regul Toxicol Pharmacol; 2003 Feb; 37(1):20-7. PubMed ID: 12662906
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Inhibitory effect of organic solvents on the mutagenicity of N-nitrosodialkylamines in Salmonella.
    Mori Y, Yamazaki H, Toyoshi K, Emi Y, Uchida K, Tsutsumi M, Konishi Y.
    Mutat Res; 1985 Apr; 142(4):153-8. PubMed ID: 3885018
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Comparative activation of 3,3'-dichlorobenzidine and related benzidines to mutagens in the Salmonella typhimurium assay by hepatic S9 and microsomes from rats pretreated with different inducers of cytochrome P-450.
    Iba MM.
    Mutat Res; 1987 Oct; 182(5):231-41. PubMed ID: 3309638
    [Abstract] [Full Text] [Related]

  • 26. Metabolic activation capabilities of S9 and hepatocytes from uninduced rats to convert carcinogenic N-nitrosamines to mutagens.
    Rumruen K, Pool BL.
    Mutat Res; 1984 Oct; 140(2-3):147-53. PubMed ID: 6379440
    [Abstract] [Full Text] [Related]

  • 27. 3-Methoxy-4-aminoazobenzene, a unique carcinogenic aromatic amine as a substrate for cytochrome-P-450-mediated mutagenesis.
    Degawa M, Kojima M, Hashimoto Y.
    Mutat Res; 1985 Oct; 152(2-3):125-9. PubMed ID: 3934534
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Mutagenicity of amine drugs and their products of nitrosation.
    Andrews AW, Lijinsky W, Snyder SW.
    Mutat Res; 1984 Feb; 135(2):105-8. PubMed ID: 6363913
    [Abstract] [Full Text] [Related]

  • 31. Salmonella/human S9 mutagenicity test: a collaborative study with 58 compounds.
    Hakura A, Shimada H, Nakajima M, Sui H, Kitamoto S, Suzuki S, Satoh T.
    Mutagenesis; 2005 May; 20(3):217-28. PubMed ID: 15843387
    [Abstract] [Full Text] [Related]

  • 32. Contribution of DNA methylation and benzylation to N-nitroso-N-benzyl-methylamine-induced mutagenesis in bacteria: effects of rat liver cytochrome P450 isozymes and glutathione transferases.
    Lin DX, Malaveille C, Park SS, Gelboin HV, Bartsch H.
    Carcinogenesis; 1990 Sep; 11(9):1653-8. PubMed ID: 2119260
    [Abstract] [Full Text] [Related]

  • 33. Activation of N-nitrosobis(2-oxopropyl)amine and N-nitroso(2-hydroxypropyl)-(2-oxopropyl)amine to mutagens for V79 cells by isolated hamster and rat pancreatic acinar cells.
    Mangino MM, Scarpelli DG, Hollenberg PF.
    Cancer Res; 1985 Nov; 45(11 Pt 1):5219-24. PubMed ID: 4053002
    [Abstract] [Full Text] [Related]

  • 34. Involvement of lauric acid hydroxylase in the activation of beta-substituted nitrosamines.
    Lawson TA.
    Cancer Lett; 1991 Aug; 59(2):177-82. PubMed ID: 1884375
    [Abstract] [Full Text] [Related]

  • 35. Effects of norharman on the mutagenicity of chlorophenylhydroxylamine and its metabolism with rat liver S9.
    Suzuki J, Kobayashi Y, Monden S, Suzuki S.
    Mutat Res; 1986 Sep; 162(2):165-72. PubMed ID: 3528827
    [Abstract] [Full Text] [Related]

  • 36. Optimizing the detection of N-nitrosamine mutagenicity in the Ames test.
    Heflich RH, Bishop ME, Mittelstaedt RA, Yan J, Guerrero SK, Sims AM, Mitchell K, Moore N, Li X, Mei N, Elespuru RK, King ST, Keire DA, Kruhlak NL, Dorsam RT, Raw AS, Davis Bruno KL, McGovern TJ, Atrakchi AH.
    Regul Toxicol Pharmacol; 2024 Nov; 153():105709. PubMed ID: 39343352
    [Abstract] [Full Text] [Related]

  • 37. Mutagenicities of N-nitrosamines on Salmonella.
    Yahagi T, Nagao M, Seino Y, Matsushima T, Sugimura T.
    Mutat Res; 1977 Apr; 48(2):121-9. PubMed ID: 406555
    [Abstract] [Full Text] [Related]

  • 38. The pH-dependent response of Salmonella typhimurium TA100 to mutagenic N-nitrosamines.
    Negishi T, Hayatsu H.
    Mutat Res; 1980 Nov; 79(3):223-30. PubMed ID: 7012604
    [Abstract] [Full Text] [Related]

  • 39. Mutagenic activation of N-nitrosobis(2-oxopropyl)amine by pancreatic juice and assessment of its ductal tumorigenicity following intraductal administration in dogs.
    Kamano T, Mori Y, Suda K, Takahashi M, Uchida T, Takada T, Tsutsumi M, Konishi Y.
    Int J Pancreatol; 1996 Aug; 20(1):51-7. PubMed ID: 8872524
    [Abstract] [Full Text] [Related]

  • 40. Distribution and metabolism of N-nitrosobis(2-hydroxypropyl)amine in rats.
    Mori Y, Takahashi H, Yamazaki H, Toyoshi K, Obara T, Makino T, Nakae D, Takahashi S, Konishi Y.
    IARC Sci Publ; 1984 Aug; (57):411-6. PubMed ID: 6533030
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.